Too many ovarian cancer patients are missing out on life-changing genetic testing

According to National Comprehensive Cancer Network guidelines, every patient diagnosed with ovarian cancer should undergo genetic testing, which can help guide treatment selection. Yet, an analysis found that just slightly more than half of these patients get tested. Evolent’s Dr. Sadie Dobrozsi speaks with Patient Power about the findings and offers recommendations for overcoming the barriers to testing.

Read article.